{"disease":{"id":"glomerulonephritis","name":"glomerulonephritis"},"drugs":{"marketed":[{"drug_id":"chlorothiazide","indication_name":"Edema in Acute Glomerulonephritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diuril","generic_name":"CHLOROTHIAZIDE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03929887","title":"KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT07330362","title":"The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.","phase":"","overall_status":"RECRUITING","enrollment_count":2900,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT04846010","title":"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"All Natural Medicine Clinic, LLC","has_results":false},{"nct_id":"NCT04662723","title":"Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":878,"lead_sponsor_name":"Fondazione Schena","has_results":false},{"nct_id":"NCT03201406","title":"Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":837,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05656963","title":"The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD","phase":"","overall_status":"UNKNOWN","enrollment_count":741,"lead_sponsor_name":"Yipeng Liu","has_results":false},{"nct_id":"NCT01560052","title":"Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":503,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT05434325","title":"TESTING -ON Post-Trial ObservatioNal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":366,"lead_sponsor_name":"The George Institute","has_results":false},{"nct_id":"NCT06792448","title":"Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":350,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT04349683","title":"Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":332,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT03955445","title":"Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":225,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06858319","title":"Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05286632","title":"KidneYou - Innovative Digital Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Advice Pharma Group srl","has_results":false},{"nct_id":"NCT05969522","title":"Stratified Therapy on Pediatric AAGN","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Wang Mo","has_results":false},{"nct_id":"NCT03357653","title":"Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":174,"lead_sponsor_name":"Ewha Womans University","has_results":false},{"nct_id":"NCT05946564","title":"A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05067127","title":"Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06753942","title":"ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT02523768","title":"Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":117,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT06249243","title":"Affection of Renal and Urinary System in IBD Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06835322","title":"Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT04428398","title":"Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT05761938","title":"A Study of Rituximab in Frontline Therapy for Glomerulonephritis","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04387448","title":"A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":96,"lead_sponsor_name":"Goldfinch Bio, Inc.","has_results":false},{"nct_id":"NCT05914155","title":"Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Shoichi Maruyama MD PhD","has_results":false},{"nct_id":"NCT06500702","title":"A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07203404","title":"A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT05505955","title":"Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Chengdu Suncadia Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05797051","title":"Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT06047171","title":"Rescue of Nephrons With ALE.F02 (RENAL-F02)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Alentis Therapeutics AG","has_results":false},{"nct_id":"NCT06757725","title":"Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT04020328","title":"Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Shenzhen Second People's Hospital","has_results":false},{"nct_id":"NCT03836144","title":"Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"European Georges Pompidou Hospital","has_results":false},{"nct_id":"NCT06623877","title":"Using Renal Elastography Measurements for Evaluation of Glomerulonephritis Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04582890","title":"US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05283057","title":"Empagliflozin in Patients With Glomerulonephritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT03184103","title":"Acute Post Streptococcal Glomerulonephritis","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03433326","title":"Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy","phase":"","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"University of Florence","has_results":false},{"nct_id":"NCT03880643","title":"Rituximab in Refractory Primary Membranous Nephropathy","phase":"","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT05546047","title":"A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"NephroNet, Inc.","has_results":false},{"nct_id":"NCT04145440","title":"Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"HI-Bio, A Biogen Company","has_results":true},{"nct_id":"NCT03841448","title":"A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":true},{"nct_id":"NCT04950114","title":"An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Goldfinch Bio, Inc.","has_results":false},{"nct_id":"NCT00977977","title":"Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT07389499","title":"A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT03832114","title":"Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04733040","title":"Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"HI-Bio, A Biogen Company","has_results":false},{"nct_id":"NCT03459443","title":"A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03453619","title":"Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}